Transforming growth factor-β1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt

Acta Cardiologica

Volumn 65, Issue 2, 2010, Pages 177-183

  Kamal, Hanan ^a   Hussein, Gehan ^a   Hassoba, Howayda ^a   Mosaad, Nesrin ^a   Gad, Amal ^a   Ismail, Mosleh ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Egypt; Genotypes; Polymorphism; Rheumatic heart

Indexed keywords

GENOMIC DNA; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC HEART DISEASE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; EGYPT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATIC HEART DISEASE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77951547539     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.65.2.2047051     Document Type: Article

References (32)

1. Carapetis JR. The current evidence for the burden of group A streptococcal diseases. Geneva, World Health Organization 2004; 1-57.
2. Mayosi BM, Robertson K, Volmink J, Adebo W, Akinyore K, Amoah A, Bannerman C, Biesman-Simons S, Carapetis J, Cilliers A, Commerford P, Croasdale A, Damasceno A, Dean J, Dean M, de Souza R, Filipe A, Hugo-Hamman C, Jurgens-Clur SA, Kombila-Koumba P, Kotzenberg C, Lawrenson J, Manga P, Matenga J, Mathivha T, Mntla P, Mocumbi A, Mokone T, Ogola E, Omokhodion S, Palweni C, Pearce A, Salo A, Thomas B, Walker K, Wiysonge C, Zaher S. The Drakensberg Declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006; 96: 246.
3. Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989; 52: 225-237 (Pubitemid 19177746)
4. Guilherme L, Cury P, Demarchi LM, Coelho V, Abel L, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto E, Pomerantzeff PM, Tanaka AC, Kalil J. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004; 165: 1583-1591
5. Fraser WJ, Haffejee Z, Jankelow D, Wadee A, Cooper K. Rheumatic Aschoff nodules revisited. II: Cytokine expression corroborates recently proposed sequential stages. Histopathology 1997; 31: 460-464 (Pubitemid 27505363)
6. Wen FQ, Liu X, Kobayashi T, Abe S, Fang Q, Kohyama T, Ertl R, Terasaki Y, Manouilova L, Rennard SI. Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads. Am J Respir Cell Mol Biol 2004; 30: 816-822 (Pubitemid 38736905)
7. Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995-1998
8. Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL. Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol 1995; 26: 452-457
9. Ignotz R, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-4345 (Pubitemid 17198877)
10. Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 1987; 262: 17467-17474
11. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997; 29: 5-17. (Pubitemid 27096415)
12. rd, Levy RJ. Progression of aortic valve stenosis: TGF-β1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003; 75: 457-65. (Pubitemid 36184488)
13. Jian B, Connolly J, Savani RC, Narula N, Liang B, Levy R. Serotonin mechanisms in heart valve disease I: Serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 2002; 161: 2111-2121 (Pubitemid 35434857)
14. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, Dietz HC. TGF beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 1586-1592 (Pubitemid 40385549)
15. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004; 95: 253-260
16. Lijnen P, Petrov V. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol 2002; 24: 333-344 (Pubitemid 34857097)
17. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-1 in cardiomyopathy, valvular disease, and arrhythmia. Immunology 2006; 118: 10-24.
18. Kim L, Kim do K, Yang WI, Shin DH, Jung IM, Park HK, Chang BC. Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J Korean Med Sci 2008; 23: 41-48
19. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factor beta 1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003; 63: 2610-2615
20. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-2787 (Pubitemid 30396007)
21. Chou HT, Chen CH, Tsai CH, Tsai FJ. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 2004; 148: 181-186
22. Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A. Single-nucleotide polymorphisms of transforming growth factor-beta 1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect 2004; 37: 145-52. (Pubitemid 38899944)
23. Shah R, Rahaman B, Hurley CK, Posch PE. Allelic diversity in the TGF-B1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 2006; 119: 61-74. (Pubitemid 43300198)
24. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560-567
25. Crow, JF. Hardy, Weinberg and language impediments. Genetics 1999; 152: 821-825
26. Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J 1997; 16: 400-407 (Pubitemid 27172961)
27. Yamada H, Watanabe M, Nanba T, Akamizu T, Iwatani Y. The + 869T/C polymorphism in the transforming growth factor-β1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol 2008; 151: 379-382 (Pubitemid 351160725)
28. Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 431-435 (Pubitemid 37046871)
29. Sugiura Y, Niimi T, Sato S, Yoshinouchi T, Banno S, Naniwa T, Maeda H, Shimizu S, Ueda R. Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 2002; 61: 826-828 (Pubitemid 34601868)
30. Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881-887 (Pubitemid 26365534)
31. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene. Transplantation 1998; 66: 1014-1020
32. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type betal. Hum Mol Genet 1999; 8: 93-97 (Pubitemid 29039053)